DE3783257T2 - Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung. - Google Patents

Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung.

Info

Publication number
DE3783257T2
DE3783257T2 DE8787105570T DE3783257T DE3783257T2 DE 3783257 T2 DE3783257 T2 DE 3783257T2 DE 8787105570 T DE8787105570 T DE 8787105570T DE 3783257 T DE3783257 T DE 3783257T DE 3783257 T2 DE3783257 T2 DE 3783257T2
Authority
DE
Germany
Prior art keywords
lys
arg
leu
peptide
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787105570T
Other languages
German (de)
English (en)
Other versions
DE3783257D1 (de
Inventor
Osamu Ito
Shinro Tachibana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3783257D1 publication Critical patent/DE3783257D1/de
Publication of DE3783257T2 publication Critical patent/DE3783257T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8787105570T 1986-04-17 1987-04-15 Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung. Expired - Fee Related DE3783257T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61086987A JPS62246595A (ja) 1986-04-17 1986-04-17 気菅支拡張作用・降圧作用ペプタイド

Publications (2)

Publication Number Publication Date
DE3783257D1 DE3783257D1 (de) 1993-02-11
DE3783257T2 true DE3783257T2 (de) 1993-05-13

Family

ID=13902213

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787105570T Expired - Fee Related DE3783257T2 (de) 1986-04-17 1987-04-15 Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung.

Country Status (10)

Country Link
US (2) US4757133A (enrdf_load_stackoverflow)
EP (1) EP0241926B1 (enrdf_load_stackoverflow)
JP (1) JPS62246595A (enrdf_load_stackoverflow)
AT (1) ATE84048T1 (enrdf_load_stackoverflow)
CA (1) CA1288894C (enrdf_load_stackoverflow)
DE (1) DE3783257T2 (enrdf_load_stackoverflow)
DK (1) DK193887A (enrdf_load_stackoverflow)
ES (1) ES2052507T3 (enrdf_load_stackoverflow)
GR (1) GR3006718T3 (enrdf_load_stackoverflow)
NO (1) NO871574L (enrdf_load_stackoverflow)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
SE8702520D0 (sv) * 1987-06-16 1987-06-16 Kabigen Ab Mammal intestine hormone precursor
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
US5234907A (en) * 1989-06-30 1993-08-10 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
JPH04193896A (ja) * 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
JPH03181499A (ja) * 1989-12-11 1991-08-07 Akira Kaji 新規ペプチド
DE69101187T2 (de) * 1990-06-26 1994-09-29 Sanwa Kagaku Kenkyusho Co VIP-Analogen und ihre Verwendung.
JPH05238950A (ja) * 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性ｖｉｐ製剤
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
US5623050A (en) * 1991-08-22 1997-04-22 Takeda Chemical Industries, Ltd. Stable polypeptides having c-AMP production enhancing activity and the use thereof
US5998368A (en) * 1991-10-31 1999-12-07 Yeda Research And Development Co. Ltd. Derivatives of structurally modified VIP and pharmaceutical compositions containing them
US5681816A (en) * 1992-04-24 1997-10-28 Korman; Louis Y. Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
US5252747A (en) * 1992-09-11 1993-10-12 Abbott Laboratories Chiral quinolone intermediates
US5856303A (en) * 1995-06-09 1999-01-05 Itoham Foods, Inc. Peptide, a bronchus-expanding agent, and a blood-flow-improving agent
KR20050067439A (ko) * 2002-11-27 2005-07-01 이토햄 가부시키가이샤 펩티드 및 이를 포함하는 의약조성물
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
EP1804820A4 (en) * 2004-10-08 2009-12-02 Transition Therapeutics Inc PHARMACEUTICAL PRODUCTS BASED ON VASOACTIVE INTESTINAL POLYPEPTIDES
US20080214440A1 (en) * 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
US20070293429A1 (en) * 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20090170775A1 (en) * 2004-10-08 2009-07-02 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide compositions
RU2009103811A (ru) * 2006-07-06 2010-08-20 Ф.Хоффманн-Ля Рош Аг (Ch) Аналоги вазоактивного интестинального пептида

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
US3862927A (en) * 1973-02-26 1975-01-28 Sami I Said Process for preparation of vasoactive intestinal peptide
US4016258A (en) * 1975-08-05 1977-04-05 Said Sami I Vasoactive intestinal peptide from fowl
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
US4822774A (en) 1989-04-18
JPS62246595A (ja) 1987-10-27
ATE84048T1 (de) 1993-01-15
ES2052507T3 (es) 1994-07-16
NO871574D0 (no) 1987-04-14
DK193887A (da) 1987-10-18
CA1288894C (en) 1991-09-10
US4757133A (en) 1988-07-12
DK193887D0 (da) 1987-04-14
EP0241926A3 (en) 1989-03-08
GR3006718T3 (enrdf_load_stackoverflow) 1993-06-30
NO871574L (no) 1987-10-19
EP0241926A2 (en) 1987-10-21
DE3783257D1 (de) 1993-02-11
EP0241926B1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DE3783257T2 (de) Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung.
DE69630133T2 (de) Analoga des parathyroid-hormons
DE69117788T2 (de) Parathyroid-Hormon-Antagonisten
CH639361A5 (de) Peptide, verfahren zu deren herstellung und pharmazeutische praeparate, welche diese als wirkstoff enthalten.
DD236536A5 (de) Verfahren zur herstellung eines synthetischen peptides
DE69207138T2 (de) Zyklische VIP-Analoge
JPH0689035B2 (ja) Ｇｒｆ類似体類
DE68914205T2 (de) Zyklische GRF-Analoge.
DE69028101T2 (de) Melaninkonzentrierende hormone und dns die diese expremieren
WO1992006998A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2647843A1 (de) Neue peptide, ihre herstellung sowie verfahren zur herstellung cyclischer peptide
DE2858718C2 (enrdf_load_stackoverflow)
DE2816854A1 (de) Somatostatinanaloga, verfahren zu ihrer herstellung und zwischenprodukte hierfuer
DE69228277T2 (de) PACAP-Derivate mit c-AMP-produzierenden Eigenschaften
DE3782010T2 (de) Vom calcitonin-gen abgeleitete peptidderivate.
DD218371A5 (de) Verfahren zur herstellung von wff analoga
DE69630583T2 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
DE3881467T2 (de) Vasokonstriktor-Peptid.
DD228266A5 (de) Verfahren zur herstellung von wff-analoga
DE2611779A1 (de) Cyclische undecapeptidanaloge von somatostatin
DE69025123T2 (de) Grf-viia-analoge
DE3850015T2 (de) Zyklische GRF-Analoga.
DE3587276T2 (de) Crf-analoga.
DE3880226T2 (de) Derivate von calcitonin verwandten gen-peptiden.
DD217808A5 (de) Verfahren zur herstellung von saeugetier-pgrf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee